Definium Therapeutics Inc. Common Shares vs Figure Technology Solutions Inc. Class A Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.5 (market cap $4.71B), while Figure Technology Solutions Inc. Class A Common Stock trades at $28.01 (market cap $6.21B). The key difference: Figure Technology Solutions Inc. Class A Common Stock is the larger of the two by market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, Figure Technology Solutions Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Figure Technology Solutions Inc. Class A Common Stock for 0 Days on average.
| DFTX | FIGR | |
|---|---|---|
Market Cap | $4.71B | $6.21B |
Volume | 1,966,636 | 4,025,182 |
Sector | Health | Financials |
52-Week High | $48.45 | $73.91 |
52-Week Low | $10.68 | $24.91 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.67B | $6.24B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Figure Technology Solutions operates a blockchain-native capital marketplace. Its platform supports loan origination, funding, sale, and trading of tokenized assets, along with digital-asset infrastructure and services.
Read more on FIGR →